PL3665173T3 - Nowy sposób syntezy amanityn - Google Patents
Nowy sposób syntezy amanitynInfo
- Publication number
- PL3665173T3 PL3665173T3 PL18746965.5T PL18746965T PL3665173T3 PL 3665173 T3 PL3665173 T3 PL 3665173T3 PL 18746965 T PL18746965 T PL 18746965T PL 3665173 T3 PL3665173 T3 PL 3665173T3
- Authority
- PL
- Poland
- Prior art keywords
- amanitins
- synthesis
- new method
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6831—Fungal toxins, e.g. alpha sarcine, mitogillin, zinniol or restrictocin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17185182 | 2017-08-07 | ||
| PCT/EP2018/071268 WO2019030173A1 (en) | 2017-08-07 | 2018-08-06 | NOVEL METHOD FOR SYNTHESIZING AMANITINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3665173T3 true PL3665173T3 (pl) | 2025-08-18 |
Family
ID=59579417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18746965.5T PL3665173T3 (pl) | 2017-08-07 | 2018-08-06 | Nowy sposób syntezy amanityn |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10961277B2 (pl) |
| EP (1) | EP3665173B1 (pl) |
| JP (1) | JP7165720B2 (pl) |
| KR (1) | KR102674750B1 (pl) |
| CN (1) | CN111051310B (pl) |
| AU (1) | AU2018314668B2 (pl) |
| BR (1) | BR112020001345A2 (pl) |
| CA (1) | CA3066867A1 (pl) |
| CL (1) | CL2020000304A1 (pl) |
| CO (1) | CO2020001259A2 (pl) |
| DK (1) | DK3665173T3 (pl) |
| ES (1) | ES3033917T3 (pl) |
| FI (1) | FI3665173T3 (pl) |
| HR (1) | HRP20250655T1 (pl) |
| HU (1) | HUE072299T2 (pl) |
| LT (1) | LT3665173T (pl) |
| MX (1) | MX2020001472A (pl) |
| PL (1) | PL3665173T3 (pl) |
| PT (1) | PT3665173T (pl) |
| RS (1) | RS66987B1 (pl) |
| SG (1) | SG11201912224PA (pl) |
| SI (1) | SI3665173T1 (pl) |
| WO (1) | WO2019030173A1 (pl) |
| ZA (1) | ZA201908158B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110997676B (zh) | 2017-08-07 | 2022-12-20 | 海德堡医药研究有限责任公司 | 合成鹅膏蕈碱的新方法 |
| JP7335260B2 (ja) * | 2017-08-18 | 2023-08-29 | バイリ－バイオ（チェンドゥ）ファーマスーティカル シーオー．，エルティーディー． | 非天然アマニチン類抗体複合物 |
| CN111989122A (zh) * | 2018-04-13 | 2020-11-24 | 海德堡医药研究有限责任公司 | 用于治疗实体瘤的靶向鹅膏毒素缀合物 |
| EP3894390A1 (en) * | 2018-12-11 | 2021-10-20 | Heidelberg Pharma Research GmbH | Synthesis of (s)-6-hydroxytryptophan and derivatives thereof |
| CA3137373A1 (en) * | 2019-04-24 | 2020-10-29 | Heidelberg Pharma Research Gmbh | Amatoxin antibody-drug conjugates and uses thereof |
| WO2021122744A1 (en) * | 2019-12-16 | 2021-06-24 | Heidelberg Pharma Research Gmbh | Synthesis of amanin and its derivatives |
| EP4161946A1 (en) * | 2020-06-09 | 2023-04-12 | Heidelberg Pharma Research GmbH | Method for synthesis of thioether-containing peptides |
| CA3208117A1 (en) | 2021-03-19 | 2022-09-22 | Torsten HECHLER | B-lymphocyte specific amatoxin antibody conjugates |
| CN115385916B (zh) * | 2021-07-01 | 2023-08-15 | 江苏师范大学 | 一种手性吲哚啉并吡咯化合物及其合成方法 |
| AU2023374571A1 (en) | 2022-11-01 | 2025-04-03 | Heidelberg Pharma Research Gmbh | Anti-gucy2c antibody and uses thereof |
| WO2024123663A1 (en) * | 2022-12-06 | 2024-06-13 | Sri International | Antimicrobial compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0463151T3 (da) | 1990-01-12 | 1996-07-01 | Cell Genesys Inc | Frembringelse af xenogene antistoffer |
| ES2371085T3 (es) | 2006-05-27 | 2011-12-27 | Faulstich, Heinz, Dr. | Utilización de conjugados de amatoxinas o falotoxinas con macromoléculas para la terapia tumoral y de la inflamación. |
| RU2011145038A (ru) | 2009-04-08 | 2013-05-20 | Дойчес Кребсфоршунгсцентрум | Несущие аматоксины мишень-связывающие молекулы для лечения рака |
| SMT202000263T1 (it) | 2009-04-08 | 2020-07-08 | Deutsches Krebsforsch | Componenti terapeutici di legame alla superficie cellulare armati di amatossina destinati alla terapia contro i tumori |
| DK2889624T3 (en) | 2009-08-10 | 2018-12-10 | Ucl Business Plc | Reversible covalent bonding of functional molecules |
| EP2436398B1 (en) * | 2010-09-30 | 2013-01-23 | Heidelberg Pharma GmbH | Amatoxin-conjugates with improved linkers |
| EP2497499A1 (en) | 2011-03-10 | 2012-09-12 | Heidelberg Pharma GmbH | Amatoxin-conjugates with improved linkages |
| EP2684865A1 (en) | 2012-07-13 | 2014-01-15 | Heidelberg Pharma GmbH | Methods for synthesizing amatoxin building block and amatoxins |
| WO2014043403A1 (en) | 2012-09-12 | 2014-03-20 | Agensys, Inc. | Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase |
| US20160220687A1 (en) * | 2015-02-02 | 2016-08-04 | National Guard Health Affairs | Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer |
| CN114395050B (zh) * | 2015-03-09 | 2025-03-14 | 海德堡医药有限责任公司 | 鹅膏毒素-抗体轭合物 |
| US10723766B2 (en) | 2015-11-27 | 2020-07-28 | Heidelberg Pharma Research Gmbh | Derivatives of gamma-amanitin |
-
2018
- 2018-08-06 SI SI201831239T patent/SI3665173T1/sl unknown
- 2018-08-06 AU AU2018314668A patent/AU2018314668B2/en active Active
- 2018-08-06 FI FIEP18746965.5T patent/FI3665173T3/fi active
- 2018-08-06 DK DK18746965.5T patent/DK3665173T3/da active
- 2018-08-06 MX MX2020001472A patent/MX2020001472A/es unknown
- 2018-08-06 PL PL18746965.5T patent/PL3665173T3/pl unknown
- 2018-08-06 ES ES18746965T patent/ES3033917T3/es active Active
- 2018-08-06 CN CN201880051375.7A patent/CN111051310B/zh active Active
- 2018-08-06 RS RS20250674A patent/RS66987B1/sr unknown
- 2018-08-06 WO PCT/EP2018/071268 patent/WO2019030173A1/en not_active Ceased
- 2018-08-06 JP JP2020506722A patent/JP7165720B2/ja active Active
- 2018-08-06 LT LTEPPCT/EP2018/071268T patent/LT3665173T/lt unknown
- 2018-08-06 EP EP18746965.5A patent/EP3665173B1/en active Active
- 2018-08-06 US US16/637,376 patent/US10961277B2/en active Active
- 2018-08-06 KR KR1020207000441A patent/KR102674750B1/ko active Active
- 2018-08-06 PT PT187469655T patent/PT3665173T/pt unknown
- 2018-08-06 CA CA3066867A patent/CA3066867A1/en active Pending
- 2018-08-06 HR HRP20250655TT patent/HRP20250655T1/hr unknown
- 2018-08-06 SG SG11201912224PA patent/SG11201912224PA/en unknown
- 2018-08-06 BR BR112020001345-5A patent/BR112020001345A2/pt not_active Application Discontinuation
- 2018-08-06 HU HUE18746965A patent/HUE072299T2/hu unknown
-
2019
- 2019-12-09 ZA ZA2019/08158A patent/ZA201908158B/en unknown
-
2020
- 2020-02-04 CO CONC2020/0001259A patent/CO2020001259A2/es unknown
- 2020-02-05 CL CL2020000304A patent/CL2020000304A1/es unknown
-
2021
- 2021-01-13 US US17/147,569 patent/US11702451B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3873883T (pt) | Método de síntese | |
| PL3665173T3 (pl) | Nowy sposób syntezy amanityn | |
| PL3658495T3 (pl) | Sposób wytwarzania gazu syntezowego | |
| GB201700937D0 (en) | Synthesis method | |
| HUE055242T2 (hu) | Omecamtiv mecarbil szintézise | |
| GB201801768D0 (en) | Synthesis method | |
| EP3133061C0 (en) | PROCESS FOR SYNTHESIS OF FLORFENICOL | |
| GB201701396D0 (en) | Novel alternating-phase synthesis method | |
| IL260169B (en) | Synthesis of a substituted indane derivative | |
| IL284374A (en) | Methods of producing ustekinumab | |
| PT3728208T (pt) | Polimorfos | |
| IL246560A0 (en) | Process for improved oxycodone synthesis | |
| EP3684780C0 (en) | SYNTHESIS OF FLOXURIDINE | |
| EP3749779A4 (en) | Library preparation | |
| PT3098219T (pt) | Método para a síntese de carbonatos cíclicos | |
| HUE055305T2 (hu) | Javított eljárás vc-seco linker-hatóanyag szintézisére | |
| DK3752507T3 (da) | Triazoloquinazolinon-syntese | |
| GB201705534D0 (en) | Drug intermediates parachlorobenzoic-acid synthesis method | |
| FI20175094A7 (fi) | Prosessi hiilivetyjen valmistamiseksi | |
| GB201705490D0 (en) | Organic synthesis intermediates 2-aminobenzothiazole synthesis method | |
| GB201705497D0 (en) | Medicine intermediates o-aminobiphenyl synthesis method | |
| DK3280704T3 (da) | Fremgangsmåde til syntese af en prækursor af en enkelt isomer af dairy-lacton | |
| GB201720968D0 (en) | Nicotinamide-N-oxide drug intermediates synthesis method | |
| GB201720972D0 (en) | 2-Hydroxyquinoxaline drug intermediates synthesis method | |
| GB201715110D0 (en) | 2-nitro-4-aminobenzaldehyde drug intermediates synthesis method |